A. T. TUĞLULAR Et Al. , "POST AUTHORIZATION SAFETY OF LENALIDOMIDE DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA IN TURKEY," 15th International Myeloma Workshop , 2015
TUĞLULAR, A. T. Et Al. 2015. POST AUTHORIZATION SAFETY OF LENALIDOMIDE DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA IN TURKEY. 15th International Myeloma Workshop .
TUĞLULAR, A. T., PEHLİVAN, M., SARI, H. İ., AYYILDIZ, M. O., SAYDAM, G., SÖNMEZ, M., ... BEŞIŞIK, S.(2015). POST AUTHORIZATION SAFETY OF LENALIDOMIDE DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA IN TURKEY . 15th International Myeloma Workshop
TUĞLULAR, AYŞE Et Al. "POST AUTHORIZATION SAFETY OF LENALIDOMIDE DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA IN TURKEY," 15th International Myeloma Workshop, 2015
TUĞLULAR, AYŞE T. Et Al. "POST AUTHORIZATION SAFETY OF LENALIDOMIDE DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA IN TURKEY." 15th International Myeloma Workshop , 2015
TUĞLULAR, A. T. Et Al. (2015) . "POST AUTHORIZATION SAFETY OF LENALIDOMIDE DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA IN TURKEY." 15th International Myeloma Workshop .
@conferencepaper{conferencepaper, author={AYŞE TÜLİN TUĞLULAR Et Al. }, title={POST AUTHORIZATION SAFETY OF LENALIDOMIDE DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA IN TURKEY}, congress name={15th International Myeloma Workshop}, city={}, country={}, year={2015}}